Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients

Diabetes Research and Clinical Practice

Volumn 106, Issue 2, 2014, Pages 312-318

  Zhang, D ^a   Zhang, L ^a   Zheng, Y ^a   Yue, F ^a   Russell, R D ^b   Zeng, Y ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Inflammation; Insulin resistance; Type 2 diabetes; Zonulin

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INTERLEUKIN 6; MEMBRANE PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ZONULIN; BIOLOGICAL MARKER; CHOLERA TOXIN;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; GLUCOSE TOLERANCE; HAN CHINESE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; WAIST HIP RATIO; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; ETHNOLOGY; GLUCOSE INTOLERANCE; MIDDLE AGED; PHYSIOLOGY; YOUNG ADULT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLERA TOXIN; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84920618880     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.08.017     Document Type: Article

References (25)

1. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
2. Cani P.D., Possemiers S., Van de Wiele T., Guiot Y., Everard A., Rottier O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
3. Brun P., Castagliuolo I., Di Leo V., Buda A., Pinzani M., Palu G., et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol - Gastrointest Liver Physiol 2007, 292:G518-G525.
4. Cani P.D., Osto M., Geurts L., Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 2012, 3:279-288.
5. Horton F., Wright J., Smith L., Hinton P.J., Robertson M.D. Increased intestinal permeability to oral chromium ((51) Cr)-EDTA in human Type 2 diabetes. Diabet Med: J Br Diabet Assoc 2014, 31:559-563.
6. Fasano A. Zonulin, regulation of tight junctions, and autoimmune diseases. Ann NY Acad Sci 2012, 1258:25-33.
7. Tripathi A., Lammers K.M., Goldblum S., Shea-Donohue T., Netzel-Arnett S., Buzza M.S., et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A 2009, 106:16799-16804.
8. Wang W., Uzzau S., Goldblum S.E., Fasano A. Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 2000, 113(Pt 24):4435-4440.
9. Smecuol E., Sugai E., Niveloni S., Vazquez H., Pedreira S., Mazure R., et al. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol 2005, 3:335-341.
10. Fasano A. Intestinal permeability and its regulation by zonulin: diagnostic and therapeutic implications. Clin Gastroenterol Hepatol 2012, 10:1096-1100.
11. Sapone A., de Magistris L., Pietzak M., Clemente M.G., Tripathi A., Cucca F., et al. Zonulin upregulation is associated with increased gut permeability in subjects with type 1 diabetes and their relatives. Diabetes 2006, 55:1443-1449.
12. Marsilio R., D'Antiga L., Zancan L., Dussini N., Zacchello F. Simultaneous HPLC determination with light-scattering detection of lactulose and mannitol in studies of intestinal permeability in pediatrics. Clin Chem 1998, 44:1685-1691.
13. Peeters M., Ghoos Y., Maes B., Hiele M., Geboes K., Vantrappen G., et al. Increased permeability of macroscopically normal small bowel in Crohn's disease. Dig Dis Sci 1994, 39:2170-2176.
14. Moreno-Navarrete J.M., Sabater M., Ortega F., Ricart W., Fernandez-Real J.M. Circulating zonulin, a marker of intestinal permeability, is increased in association with obesity-associated insulin resistance. PLoS ONE 2012, 7:e37160.
15. Zak-Golab A., Kocelak P., Aptekorz M., Zientara M., Juszczyk L., Martirosian G., et al. Gut microbiota, microinflammation, metabolic profile, and zonulin concentration in obese and normal weight subjects. Int J Endocrinol 2013, 2013:674106.
16. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., et al. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002, 55:65-85.
17. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
18. Katz A., Nambi S.S., Mather K., Baron A.D., Follmann D.A., Sullivan G., et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000, 85:2402-2410.
19. Watts T., Berti I., Sapone A., Gerarduzzi T., Not T., Zielke R., et al. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci U S A 2005, 102:2916-2921.
20. Leffler D.A., Kelly C.P., Abdallah H.Z., Colatrella A.M., Harris L.A., Leon F., et al. A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge. Am J Gastroenterol 2012, 107:1554-1562.
21. Jayashree B., Bibin Y.S., Prabhu D., Shanthirani C.S., Gokulakrishnan K., Lakshmi B.S., et al. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol Cell Biochem 2014, 388:203-210.
22. Brock M., Trenkmann M., Gay R.E., Gay S., Speich R., Huber L.C. MicroRNA-18a enhances the interleukin-6-mediated production of the acute-phase proteins fibrinogen and haptoglobin in human hepatocytes. J Biol Chem 2011, 286:40142-40150.
23. Goff D.C., D'Agostino R.B., Haffner S.M., Otvos J.D. Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study. Metabolism 2005, 54:264-270.
24. Geurts L., Neyrinck A.M., Delzenne N.M., Knauf C., Cani P.D. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes 2014, 5:3-17.
25. Gummesson A., Carlsson L.M., Storlien L.H., Backhed F., Lundin P., Lofgren L., et al. Intestinal permeability is associated with visceral adiposity in healthy women. Obesity 2011, 19:2280-2282.